Histological surprise, mammary analogue secretory carcinoma of parotid gland

Authors

  • Iram T. Pasha Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India http://orcid.org/0000-0002-6621-7224
  • Akhila K. Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India
  • Ravikumar V. Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India
  • Sandeep Kumar Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2349-2902.isj20214776

Keywords:

Mammary analogue secretary carcinoma, MASC, Parotid gland, parotidectomy

Abstract

A recent described entity, mammary analogue secretary carcinoma (MASC) in 2010 by Skalova et al whose morphological and immunohistochemical features are similar in secretory carcinoma of the breast and salivary gland. This is a low-grade carcinoma which presents as a firm, slow-growing, circumscribed lesion with male preponderance. We present a case report of MASC.

Metrics

Metrics Loading ...

Author Biographies

Iram T. Pasha, Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India

MS General Surgery

3rd year resident 

Akhila K., Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India

MS General Surgery

3rd year resident 

Ravikumar V., Department of surgery, MVJ MC, RH, Bangalore, Karnataka, India

MS General Surgery

Professor 

References

Nisar Z, Pol JN, Jagdale RV, Phadke MD, Kadkol GA. Mammary analogue secretory carcinoma: An Indi. an experience of a novel entity. Indian J Pathol Microbiol 2020;63(S1):134-40.

Inaki R, Abe M, Zong L, Abe T, Shinozaki-Ushiku A, Ushiku T et al. Secretory carcinoma—impact of translocation and gene fusions on salivary gland tumor. Chinese Journal of Cancer Research. 2017;29(5):379.

Patel KR, Solomon IH, El-Mofty SK, Lewis JS, Chernock RD. Mammaglobin and S-100 protein immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma. Hum Pathol. 2013;44:25018.

Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599-608.

Tognon CE, Somasiri AM, Evdokimova VE, Trigo G, Uy EE, Melnyk N et al. ETV6-NTRK3- mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res 2011;71:1060-70.

Chiosea SI, Griffith C, Assad A, Seethala RR. Clinicopathological characterization of mammary analogue carcinoma of salivary glands. Histopathology. 2012;61:387-94.

Skálová A, Vanecek T, Majewska H, Laco J, Grossmann P, Simpson RHW et al. Mammary analogue secretory carcinoma of salivary glands with high grade transformation: report of three cases with the ETV6- NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR and CCND1 genes. Am J Surg Pathol. 2011;38:23-33.

Taipale M, Krykbaeva I, Whitesell L, Santagata S, Zhang J, Liu Q et al. Chaperones as thermody- namic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells. Nat Biotechnol. 2013;31:630-7.

Downloads

Published

2021-11-26

How to Cite

Pasha, I. T., K., A., V., R., & Kumar, S. (2021). Histological surprise, mammary analogue secretory carcinoma of parotid gland. International Surgery Journal, 8(12), 3731–3734. https://doi.org/10.18203/2349-2902.isj20214776

Issue

Section

Case Reports